转分化和编程细胞死亡之间的决策点控制KRAS依赖的胰腺癌发展控制
Anne T Schneider1, Christiane Koppe1, Emilie Crouchet2
1Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty at Heinrich-Heine-University, Duesseldorf, Germany.
Nature communications
|February 19, 2025
概括
转化生长因子β激活激酶1 (TAK1) 在胰腺癌发育过程中防止细胞死亡. 抑制TAK1在胰腺管腺癌 (PDAC) 细胞中触发了编程细胞死亡 (PCD),提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 由KRAS突变驱动的Acinar-to-ductal metaplasia (ADM) 是胰腺管道腺癌 (PDAC) 发展的关键早期事件.
- 编程细胞死亡 (PCD) 途径在KRAS驱动的ADM和随后的PDAC进展中的作用尚未完全理解.
研究的目的:
- 调查细胞死亡调节器在KRAS驱动的ADM中的参与.
- 确定在PDAC启动过程中防止转化细胞被消除的分子机制.
- 评估针对PDAC中细胞存活的关键调节者的治疗潜力.
主要方法:
- 使用了转基因小鼠模型和初级细胞和有机体培养.
- 在KRAS驱动的ADM期间检查了编程细胞死亡 (PCD) 调节者的表达和活性.
- 研究了转化生长因子β激活激酶1 (TAK1) 在调节细胞存活和PCD中的作用.
- 评估了药理TAK1抑制对患者衍生PDAC有机体的影响.
主要成果:
- 在KRAS驱动的ADM过程中,PCD的关键调节者受到上调调节,使细胞死亡.
- 发现转化生长因子β激活激酶1 (TAK1) 抑制受体相互作用蛋白激酶1 (RIPK1) 介导的亡和亡,从而阻止转化细胞的清除.
- 药理上抑制TAK1成功诱导患者衍生PDAC有机体中的PCD.
- 抑制TAK1诱导的细胞死亡并没有引发与损伤相关的显著炎症反应.
结论:
- 在ADM期间,TAK1在抑制自发PCD方面发挥着至关重要的作用,支持PDAC发育所需的细胞可塑性.
- 向TAK1代表了通过诱导PCD而不会引起重大炎症来预防和治疗PDAC的有希望的治疗策略.
相关概念视频
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


